17.41USD-2.14%Mkt Cap: 1.80B USDP/E: —Last update: 2026-06-01
Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory condit…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.80B USD
Enterprise Value1.35B USD
Revenue (TTM)71.78M USD
Gross Profit-259.60M USD
Net Income (TTM)-264.46M USD
Revenue/Share0.7690 USD
Last Price17.41 USD
Fiscal Year EndNov 2025
MR QuarterFeb 2026
Employees317
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.20
PEG—
EV/EBITDA-4.40
EV/Revenue18.85
P/S25.59
P/B3.82
EPS (TTM)-3.17
EPS (Forward)-2.86
52W Range
8.19564% of range22.50
52W High22.50 USD
52W Low8.195 USD
Profitability
Gross Margin0.00%
Oper. Margin-1479.45%
EBITDA Margin0.00%
Profit Margin-314.90%
ROE-49.09%
ROA-38.43%
Growth
Revenue Growth-66.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-249.47M USD
CapEx (TTM)14.00M USD
FCF Margin-202.65%
FCF Yield-8.10%
Net Debt-482.08M USD
Net Debt/EBITDA1.57
Balance Sheet
Debt/Equity0.10
Current Ratio6.01
Quick Ratio5.89
Book Value/Sh4.651 USD
Cash/Share5.229 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)30.18 USD
Target Range23.00 USD – 41.00 USD
# Analysts17
Ownership
Shares Out.103.41M
Float82.40M
Insiders1.09%
Institutions114.88%
Short Interest
Short Ratio21.6d
Short % Float18.22%
Short % Out.18.02%
Shares Short18.63M
Short (prev mo.)19.20M
Technical
SMA 5016.18 (+7.6%)
SMA 20014.58 (+19.4%)
Beta1.88
S&P 52W Chg27.94%
Avg Vol (30d)893.27K
Avg Vol (10d)1.22M
Technical Indicators
RSI (14)62.7
MACD0.3273
MACD Signal0.1596
MACD Hist.+0.1677
BB Upper18.13 USD
BB Middle16.64 USD
BB Lower15.15 USD
BB Width17.94%
ATR (14)0.8022 USD
Vol Ratio (20d)0.51x